Critical appraisal of the use of regorafenib in the management of colorectal cancer

The lack of valid clinical management options for patients affected by metastatic colorectal cancer, which has progressed after all approved standard treatments, has lead to research into new active molecules. Regorafenib is an oral small-molecule multi kinase inhibitor, binding to several intracell...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2013
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3628528/
https://ncbi.nlm.nih.gov/pubmed/23610528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S34281
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires